UROLOGIX INC Inactive Instrument
Company Urologix Inc Nasdaq
Equities
US9172731047
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 2015 | Urologix Conducting A Strategic Review | CI |
Business Summary
Sales per Business
| USD in Million | 2013 | Weight | 2014 | Weight | Delta |
|---|---|---|---|---|---|
Medical Products
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Sales per region
| USD in Million | 2013 | Weight | 2014 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 17 | 100.0 % | 14 | 100.0 % | -14.20% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 28/05/91 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 31/03/15 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 15/06/11 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 28/05/91 |
Sidney Emery
BRD | Director/Board Member | 74 | 30/09/05 |
| Director/Board Member | 57 | 05/08/10 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 21,817,726 | 21,817,726 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Urologix, Inc.
14405 21st Avenue North
55447-4699, Minneapolis
+
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +2.06% | 211B | |
| +5.69% | 185B | |
| +29.31% | 158B | |
| +2.36% | 64.32B | |
| +18.36% | 55.66B | |
| -1.92% | 48.41B | |
| -8.37% | 37.82B | |
| -1.37% | 35.57B | |
| +8.67% | 28.12B |
- Stock Market
- Equities
- ULGX Stock
- Stock
- Company Urologix Inc
